The University of Wisconsin–Madison graduate programs are once again ranked among the nation’s best in the 2024-25 edition of U.S. News & World Report’s “Best Graduate Schools,” including ranking the School of Education first overall in the country....
Kenneth Poss, a biologist who explores the potential life-saving mechanisms of how organisms regenerate damaged heart and spinal cord tissue will join the University of Wisconsin–Madison and the Morgridge Institute for Research this fall....
Building on a previously patented method for producing paracetamol – the active ingredient in Tylenol – the discovery promises a greener path to one of the world’s most widely used medicines and other chemicals....
“This collaboration supports our mission to help eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment,” said Kevin Conroy, chairman and chief executive officer, Exact Sciences....
From networking, to funding, to hiring top talent and everything in-between, an increasing number of biohealth startups are calling the Badger State home....
Company Announces Opening of a Second R&D site in Philadelphia, PA, and the Appointments of Shelley Allen as Head of Drug Discovery, and Munir Mosaheb as Head of Biology...
In a new study from CommercialCafe ranking the country’s 20 best cities for career flexibility, Madison placed fourth among the Midwest’s top 10. The study awarded the cities points for indicators in the following categories: flexibility opportunities, commuting and remote readiness, and career growth and...
Twenty-five entries representing broad sectors such as advanced manufacturing, business services, information technology and life sciences will compete in the finalist round of the 2024 Wisconsin Governor’s Business Plan Contest. The contestants have emerged after two rounds of judging in the contest organized through the...
MADISON, Wis. --(BUSINESS WIRE)-- Exact Sciences Corp., in collaboration with Mayo Clinic Comprehensive Cancer Center, reported on data showing high sensitivity and specificity for the non-endoscopic Oncoguard® Esophagus test that is currently in development for the detection of esophageal adenocarcinoma (EAC) and its precursors, including Barrett’s...
In the latest episode of “WisBusiness.com: The Show,” Lauren Usher of gener8tor talks about the accelerator’s state, national and even international footprint as it works to provide opportunities for entrepreneurs. The Show also previews recent and upcoming Tech Council events....